SB 1096 (2022) -  Regulation of Compounded Drug Products

by Brodeur
Requiring the Surgeon General, on behalf of the Department of Health, to sign and become a party to the United States Food and Drug Administration’s Memorandum of Understanding Addressing Certain Distributions of Compounded Human Drug Products; requiring certain pharmacy permittees to annually report information to the National Association of Boards of Pharmacy’s information sharing network as required by the memorandum, etc.
Effective Date: Except as otherwise expressly provided in this act, this act shall take effect upon becoming a law
Last Event: 03/14/22 S Died in Health Policy on Monday, March 14, 2022 1:02 PM

Referred Committees and Committee Actions

Senate Referrals

  • Health Policy
  • Regulated Industries
  • Rules

Related Bills

Staff Analysis

(None Available)

Vote History

(No Votes Recorded)

Bill History

Event Time Member Committee Ver.
Event: S Died in Health Policy Time: 03/14/2022 - 1:02 PM Member: Committee: Health Policy Version: __
Event: S Indefinitely postponed and withdrawn from consideration Time: 03/12/2022 - 12:00 AM Member: Committee: Version: __
Event: S Introduced -SJ 73 Time: 01/11/2022 - 11:01 AM Member: Committee: Version: __
Event: S Referred to Health Policy; Regulated Industries; Rules -SJ 73 Time: 12/13/2021 - 10:39 AM Member: Committee: Health Policy Version: __
Event: S Filed Time: 11/30/2021 - 2:12 PM Member: Committee: Version: __

Statutes Referenced by this Bill

Statute Other Bill Citations
465.036